Childhood vaccination requirements: Lessons from history, Mississippi, and a path forward

Philip B Cawkwell1, David Oshinsky2

  • 1New York University School of Medicine, New York, NY, USA.

Vaccine
|September 27, 2015
PubMed

Insights

Mississippi achieves over 99% measles-mumps-rubella (MMR) vaccination rates, offering a model for public health. This success in childhood vaccination, despite challenges, highlights the importance of robust public health infrastructure and legal frameworks.

Area of Science:

  • Public Health
  • Immunization Policy
  • Legal History

Background:

  • Mississippi leads the US in childhood vaccination rates, particularly for measles-mumps-rubella (MMR).
  • This success is notable given the state's general public health challenges and rising vaccine resistance nationwide.
  • Understanding Mississippi's approach is crucial in light of recent measles outbreaks.

Purpose of the Study:

  • To examine the historical and legal factors contributing to Mississippi's high childhood vaccination rates.
  • To analyze the evolution of the anti-vaccination movement and its challenges.
  • To evaluate Mississippi's vaccination system as a potential model for national policy.

Main Methods:

  • Historical analysis of vaccination laws and landmark court cases.
  • Review of public health infrastructure and legal frameworks in Mississippi.
  • Examination of contemporary vaccination legislation and policy debates.

Main Results:

  • Mississippi has a long-standing and successful public health infrastructure supporting high vaccination rates.
  • The state has effectively navigated legal challenges to compulsory vaccination laws.
  • A historical analysis reveals the enduring nature of anti-vaccination sentiments and legal battles.

Conclusions:

  • Mississippi's success provides a valuable case study for improving childhood vaccination rates nationally.
  • The state's legal and public health framework serves as a model for overcoming vaccination resistance.
  • Sustaining high vaccination rates requires continuous adaptation to legal and social challenges.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
54.0K
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
43
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
72
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
699
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
59